Elekta (OTCMKTS:EKTAY) Shares Gap Up – Here’s What Happened

Elekta AB (OTCMKTS:EKTAY) gapped up before the market opened on Friday. The stock had previously closed at $5.41, but opened at $5.73. Elekta shares last traded at $5.73, with a volume of 507 shares changing hands.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded shares of Elekta from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 28th. One analyst has rated the stock with a Hold rating. According to MarketBeat.com, Elekta presently has a consensus rating of “Hold”.

Elekta Stock Up 2.9%

The firm has a market cap of $2.11 billion, a PE ratio of -47.75 and a beta of 1.03. The business’s 50-day simple moving average is $5.39 and its 200 day simple moving average is $5.49. The company has a current ratio of 0.86, a quick ratio of 0.62 and a debt-to-equity ratio of 0.45.

Elekta (OTCMKTS:EKTAY) last issued its quarterly earnings data on Thursday, August 27th. The company reported $0.07 EPS for the quarter. Elekta had a negative net margin of 2.38% and a positive return on equity of 13.47%. The company had revenue of $372.30 million during the quarter. As a group, equities research analysts expect that Elekta AB will post 0.43 earnings per share for the current year.

About Elekta

Elekta AB is a Sweden-based medical technology company that develops and supplies systems and software for radiation therapy, radiosurgery and related cancer-care applications. Its solutions are designed to help hospitals and clinics treat tumors while supporting more precise, personalized and less invasive care.

The company’s portfolio includes linear accelerators, stereotactic radiosurgery systems, magnetic resonance-guided radiation therapy technology and brachytherapy products. Elekta also provides oncology information systems and workflow software, including platforms used for treatment planning, patient management and clinical data coordination.

Founded in 1972 by neurosurgeon and inventor Lars Leksell, Elekta initially focused on radiosurgery and later expanded into broader radiation oncology.